• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化肿瘤患者使用半剂量F-氟脱氧葡萄糖进行全身正电子发射断层扫描/计算机断层扫描的采集时间。

Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose F-fluorodeoxyglucose in oncology patients.

作者信息

He Yibo, Gu Yushen, Yu Haojun, Wu Bing, Wang Siyang, Tan Hui, Cao Yanyan, Chen Shuguang, Sui Xiuli, Zhang Yiqiu, Shi Hongcheng

机构信息

Shanghai Institute of Medical Imaging, Shanghai, 200032, China.

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

出版信息

EJNMMI Phys. 2022 Jul 8;9(1):45. doi: 10.1186/s40658-022-00474-y.

DOI:10.1186/s40658-022-00474-y
PMID:35802280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9270529/
Abstract

BACKGROUND

The present study aimed to explore the boundary of acquisition time and propose an optimized acquisition time range for total-body positron emission tomography (PET)/computed tomography (CT) oncological imaging using half-dose (1.85 MBq/kg) F-fluorodeoxyglucose activity based on diagnostic needs.

METHODS

In this retrospective study based on a total-body PET system (uEXPLORER), an exploration cohort (October 2019-December 2019) of 46 oncology patients was first studied. The acquisition time for all patients was 15 min, and the acquired images were reconstructed and further split into 15-, 8-, 5-, 3-, 2-, and 1-min duration groups (abbreviated as G15, G8, G5, G3, G2, and G1). The image quality and lesion detectability of reconstructed PET images with different acquisition times were evaluated subjectively (5-point scale, lesion detection rate) and objectively (standardized uptake values, tumor-to-background ratio). In the same way, the initial optimized acquisition times were further validated in a cohort of 147 oncology patients (December 2019-June 2021) by using the Gs images (the images obtained using the 15- and 10-min acquisition times) as controls.

RESULTS

In the exploration cohort, the subjective scores for G1, G2, G3, G5, and G8 images were 2.0 ± 0.2, 2.9 ± 0.3, 3.0 ± 0.0, 3.9 ± 0.2, and 4.2 ± 0.4, respectively. Two cases in G1 were rated as 1 point. No significant difference in scores was observed between G5 and G8 (p > 0.99). In general, groups with a longer acquisition time showed lower background uptake and lesion conspicuity. Compared with G15, lesion detection rate significantly reduced to 85.3% in G1 (p < 0.05). In the validation cohort, the subjective score was 3.0 ± 0.2 for G2, 3.0 ± 0.1 for G3, 3.6 ± 0.5 for G5, 4.0 ± 0.3 for G8, and 4.4 ± 0.5 for Gs. Only the scores between G2 and G3 were not significantly different (p > 0.99). The detection rates (204 lesions) significantly reduced to 94.1-90.2% in G3 and G2 (all p < 0.05).

CONCLUSION

A 2-min acquisition time provided acceptable performance in certain groups and specific medical situations. And protocols with acquisition times ≥ 5 min could provide comparable lesion detectability as regular protocols, showing better compatibility and feasibility with clinical practice.

摘要

背景

本研究旨在探索采集时间的边界,并根据诊断需求,基于半剂量(1.85MBq/kg)F-氟脱氧葡萄糖活性,为全身正电子发射断层扫描(PET)/计算机断层扫描(CT)肿瘤成像提出优化的采集时间范围。

方法

在这项基于全身PET系统(uEXPLORER)的回顾性研究中,首先对46例肿瘤患者的探索队列(2019年10月至2019年12月)进行研究。所有患者的采集时间均为15分钟,采集到的图像进行重建,并进一步分为15分钟、8分钟、5分钟、3分钟、2分钟和1分钟时长组(简称为G15、G8、G5、G3、G2和G1)。采用主观(5分制,病变检出率)和客观(标准化摄取值、肿瘤与本底比值)方法评估不同采集时间重建的PET图像的图像质量和病变可探测性。同样,以Gs图像(使用15分钟和10分钟采集时间获得的图像)作为对照,在147例肿瘤患者队列(2019年12月至2021年6月)中进一步验证初始优化的采集时间。

结果

在探索队列中,G1、G2、G3、G5和G8图像的主观评分分别为2.0±0.2、2.9±0.3、3.0±0.0、3.9±0.2和4.2±0.4。G1组中有2例评分为1分。G5和G8之间的评分无显著差异(p>0.99)。总体而言,采集时间较长的组背景摄取较低,病变清晰度较高。与G15相比,G1组的病变检出率显著降至85.3%(p<0.05)。在验证队列中,G2的主观评分为3.0±0.2,G3为3.0±0.1,G5为3.6±0.5,G8为4.0±0.3,Gs为4.4±0.5。只有G2和G3之间的评分无显著差异(p>0.99)。G3和G2组的检出率(204个病变)显著降至94.1%-90.2%(均p<0.05)。

结论

2分钟的采集时间在某些组和特定医疗情况下可提供可接受的性能。采集时间≥5分钟的方案与常规方案相比,病变可探测性相当,在临床实践中显示出更好的兼容性和可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/d6d99d519155/40658_2022_474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/2f47d0b9cd77/40658_2022_474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/91a294e241cd/40658_2022_474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/0ac8118cd611/40658_2022_474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/d6d99d519155/40658_2022_474_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/2f47d0b9cd77/40658_2022_474_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/91a294e241cd/40658_2022_474_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/0ac8118cd611/40658_2022_474_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb96/9270529/d6d99d519155/40658_2022_474_Fig4_HTML.jpg

相似文献

1
Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose F-fluorodeoxyglucose in oncology patients.优化肿瘤患者使用半剂量F-氟脱氧葡萄糖进行全身正电子发射断层扫描/计算机断层扫描的采集时间。
EJNMMI Phys. 2022 Jul 8;9(1):45. doi: 10.1186/s40658-022-00474-y.
2
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.探讨结直肠癌超低剂量全身 [18F]-FDG PET/CT:初步经验。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1002-1011. doi: 10.1007/s00259-021-05537-3. Epub 2021 Aug 30.
3
Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.18 F-FDG 全身 PET/CT 半剂量与全剂量在结直肠癌患者中的比较。
Nucl Med Commun. 2022 Aug 1;43(8):928-936. doi: 10.1097/MNM.0000000000001589. Epub 2022 May 30.
4
Head-to-head intra-individual comparison of total-body 2-[F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?头对头个体内比较全身 2-[F]FDG PET/CT 和数字 PET/CT 在恶性肿瘤患者中的应用:它能有多敏感?
Eur Radiol. 2023 Nov;33(11):7890-7898. doi: 10.1007/s00330-023-09825-4. Epub 2023 Jun 20.
5
Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.全身 PET/CT 使用半剂量 FDG 与常规全剂量 FDG 在肺癌中的比较。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1966-1975. doi: 10.1007/s00259-020-05091-4. Epub 2020 Nov 27.
6
Low dose optimization for total-body 2-[F]FDG PET/CT imaging: a single-center study on feasibility based on body mass index stratification.基于体重指数分层的全身2-[F]FDG PET/CT成像低剂量优化:一项单中心可行性研究
Eur Radiol. 2025 Apr;35(4):1881-1893. doi: 10.1007/s00330-024-11039-1. Epub 2024 Aug 30.
7
Image quality and lesion detectability in low-dose pediatric F-FDG scans using total-body PET/CT.使用全身 PET/CT 进行低剂量小儿 F-FDG 扫描的图像质量和病变检出率。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3378-3385. doi: 10.1007/s00259-021-05304-4. Epub 2021 Mar 18.
8
The image quality, lesion detectability, and acquisition time of F-FDG total-body PET/CT in oncological patients.F-FDG全身PET/CT在肿瘤患者中的图像质量、病变可检测性及采集时间。
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2507-2515. doi: 10.1007/s00259-020-04823-w. Epub 2020 May 18.
9
Investigation of the quarter-dose 18 F-FDG total-body PET in routine clinical practice and its clinical value.四分之一剂量18F-FDG全身PET在常规临床实践中的研究及其临床价值。
Nucl Med Commun. 2023 Dec 1;44(12):1176-1183. doi: 10.1097/MNM.0000000000001777. Epub 2023 Oct 12.
10
Total-body F-FDG PET/CT scan in oncology patients: how fast could it be?肿瘤患者全身 F-FDG PET/CT 扫描:能有多快?
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2384-2394. doi: 10.1007/s00259-021-05357-5. Epub 2021 Apr 18.

引用本文的文献

1
Unveiling the biological side of PET-derived biomarkers: a simulation-based approach applied to PDAC assessment.揭示PET衍生生物标志物的生物学特性:一种应用于胰腺癌评估的基于模拟的方法。
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1708-1722. doi: 10.1007/s00259-024-06958-6. Epub 2024 Nov 26.
2
Expert consensus on workflow of PET/CT with long axial field-of-view.长轴向视野PET/CT工作流程专家共识
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3):1038-1049. doi: 10.1007/s00259-024-06968-4. Epub 2024 Nov 9.
3
Low dose optimization for total-body 2-[F]FDG PET/CT imaging: a single-center study on feasibility based on body mass index stratification.

本文引用的文献

1
Ultrafast 30-s total-body PET/CT scan: a preliminary study.30 秒全身快速 PET/CT 扫描:初步研究。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2504-2513. doi: 10.1007/s00259-022-05838-1. Epub 2022 May 17.
2
Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low F-FDG Activity.使用超低 F-FDG 活性的全身 PET/CT 进行采集的可行性。
J Nucl Med. 2022 Jun;63(6):959-965. doi: 10.2967/jnumed.121.262038. Epub 2021 Sep 30.
3
Total-body F-FDG PET/CT scan in oncology patients: how fast could it be?肿瘤患者全身 F-FDG PET/CT 扫描:能有多快?
基于体重指数分层的全身2-[F]FDG PET/CT成像低剂量优化:一项单中心可行性研究
Eur Radiol. 2025 Apr;35(4):1881-1893. doi: 10.1007/s00330-024-11039-1. Epub 2024 Aug 30.
4
Clinical Performance Comparison of a Long Versus a Short Axial Field-of-View PET/CT Using EARL-Compliant Reconstructions.使用符合 EARL 标准的重建方法,比较长轴向视野与短轴向视野 PET/CT 的临床性能。
Mol Imaging Biol. 2024 Oct;26(5):780-789. doi: 10.1007/s11307-024-01939-5. Epub 2024 Aug 2.
5
Combined whole-body dynamic and static PET/CT with low-dose [F]PSMA-1007 in prostate cancer patients.全身动态和静态 PET/CT 联合低剂量 [F]PSMA-1007 在前列腺癌患者中的应用。
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):2137-2150. doi: 10.1007/s00259-024-06620-1. Epub 2024 Jan 30.
6
Long axial field of view PET/CT in critically ill patients: lessons from a case report.危重症患者的长轴视野PET/CT:一例病例报告的经验教训
Front Med (Lausanne). 2024 Jan 4;10:1347791. doi: 10.3389/fmed.2023.1347791. eCollection 2023.
7
The earliest optimal timing for total-body Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study.全身镓纤维母细胞激活蛋白抑制剂-04正电子发射断层扫描的最早最佳时机:一项基于证据的单中心研究。
Eur Radiol. 2024 Jul;34(7):4550-4560. doi: 10.1007/s00330-023-10264-4. Epub 2023 Dec 18.
8
Image Quality and Quantitative PET Parameters of Low-Dose [F]FDG PET in a Long Axial Field-of-View PET/CT Scanner.长轴视野PET/CT扫描仪中低剂量[F]FDG PET的图像质量和定量PET参数
Diagnostics (Basel). 2023 Oct 18;13(20):3240. doi: 10.3390/diagnostics13203240.
9
Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies.长轴向视野(LAFOV)PET-CT:在静态和动态肿瘤学研究中的应用。
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3354-3362. doi: 10.1007/s00259-023-06222-3. Epub 2023 Apr 20.
10
Application of the long axial field-of-view PET/CT with low-dose [F]FDG in melanoma.长轴向视野 PET/CT 联合低剂量 [F]FDG 在黑色素瘤中的应用。
Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1158-1167. doi: 10.1007/s00259-022-06070-7. Epub 2022 Dec 7.
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2384-2394. doi: 10.1007/s00259-021-05357-5. Epub 2021 Apr 18.
4
Physical characteristics of Ga DOTATATE PET/CT affecting small lesion detectability.镓 DOTATATE PET/CT 的物理特性对小病灶可检测性的影响。
Am J Nucl Med Mol Imaging. 2021 Feb 15;11(1):27-39. eCollection 2021.
5
Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of F-FDG in healthy volunteers.超低活度全身动态 PET 成像可与全活度 PET 成像具有同等性能,用于研究健康志愿者中 F-FDG 的动力学指标。
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2373-2383. doi: 10.1007/s00259-020-05173-3. Epub 2021 Jan 22.
6
Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.全身 PET/CT 使用半剂量 FDG 与常规全剂量 FDG 在肺癌中的比较。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1966-1975. doi: 10.1007/s00259-020-05091-4. Epub 2020 Nov 27.
7
Total-Body PET/Computed Tomography Highlights in Clinical Practice: Experiences from Zhongshan Hospital, Fudan University.全身正电子发射断层扫描/计算机断层扫描在临床实践中的应用亮点:来自复旦大学中山医院的经验。
PET Clin. 2021 Jan;16(1):9-14. doi: 10.1016/j.cpet.2020.09.007.
8
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View.基于 NEMA NU 2-2018 对 uEXPLORER 全身 PET/CT 扫描仪进行性能评估,并用额外的测试来对长轴向视野的 PET 扫描仪进行特性描述。
J Nucl Med. 2021 Jun 1;62(6):861-870. doi: 10.2967/jnumed.120.250597. Epub 2020 Oct 2.
9
State of the art in total body PET.全身正电子发射断层扫描(PET)的技术现状
EJNMMI Phys. 2020 May 25;7(1):35. doi: 10.1186/s40658-020-00290-2.
10
The image quality, lesion detectability, and acquisition time of F-FDG total-body PET/CT in oncological patients.F-FDG全身PET/CT在肿瘤患者中的图像质量、病变可检测性及采集时间。
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2507-2515. doi: 10.1007/s00259-020-04823-w. Epub 2020 May 18.